Local renal autoantibody production in lupus nephritis

Journal of the American Society of Nephrology

Volumn 22, Issue 2, 2011, Pages 296-305

  Espeli, Marion ^a   Bökers, Susanne ^a   Giannico, Giovanna ^c   Dickinson, Harriet A ^a   Bardsley, Victoria ^b   Fogo, Agnes B ^c   Smith, Kenneth G C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD19 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G; LEUKOSIALIN;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CHILD; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY CORTEX; KIDNEY MEDULLA; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PLASMA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 79551677401     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010050515     Document Type: Article

References (56)

1. Fairhurst AM, Wandstrat AE, Wakeland EK: Systemic lupus erythematosus: Multiple immunological phenotypes in a complex genetic disease. Adv Immunol 92: 1-69, 2006 (Pubitemid 44828118)
2. Shlomchik MJ, Craft JE, Mamula MJ: From T to B and back again: Positive feedback in systemic autoimmune disease. Nat Rev Immunol 1: 147-153, 2001
3. Jacobi AM, Diamond B: Balancing diversity and tolerance: Lessons from patients with systemic lupus erythematosus. J Exp Med 202: 341-344, 2005 (Pubitemid 41126950)
4. Hoyer BF, Moser K, Hauser AE, Peddinghaus A, Voigt C, Eilat D, Radbruch A, Hiepe F, Manz RA: Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 199: 1577-1584, 2004
5. Dal Porto JM, Haberman AM, Shlomchik MJ, Kelsoe G: Antigen drives very low affinity B cells to become plasmacytes and enter germinal centers. J Immunol 161: 5373-5381, 1998
6. Smith KGC, Hewitson TD, Nossal GJV, Tarlinton DM: The phenotype and fate of the antibody-forming cells of the splenic foci. Eur J Immunol 26: 444-448, 1996
7. Smith KGC, Light A, Nossal GJV, Tarlinton DM: The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J 16: 2996-3006, 1997 (Pubitemid 27234939)
8. Phan TG, Paus D, Chan TD, Turner ML, Nutt SL, Basten A, Brink R: High affinity germinal center B cells are actively selected into the plasma cell compartment. J Exp Med 203: 2419-2424, 2006
9. Manz RA, Thiel A, Radbruch A: Lifetime of plasma cells in the bone marrow. Nature 388: 133-134, 1997
10. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KGC, Dorner T, Hiepe F: Competence and competition: The challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6: 741-750, 2006
11. Slifka MK, Antia R, Whitmire JK, Ahmed R: Humoral immunity due to long-lived plasma cells. Immunity 8: 363-372, 1998 (Pubitemid 28188896)
12. Benner R, Hijmans W, Haaijman JJ: The bone marrow: The major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol 46: 1-8, 1981 (Pubitemid 11005061)
13. Minges Wols HA, Underhill GH, Kansas GS, Witte PL: The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J Immunol 169: 4213-4221, 2002
14. Cassese G, Arce S, Hauser AE, Lehnert K, Moewes B, Mostarac M, Muehlinghaus G, Szyska M, Radbruch A, Manz RA: Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol 171: 1684-1690, 2003
15. O'Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, Lin LL, Mantchev GT, Bram RJ, Noelle RJ: BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 199: 91-98, 2004
16. Jongstra-Bilen J, Vukusic B, Boras K, Wither JE: Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli. J Immunol 159: 5810-5820, 1997 (Pubitemid 127471515)
17. Theofilopoulos AN, Shawler DL, Eisenberg RA, Dixon FJ: Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. J Exp Med 151: 446-466, 1980
18. Holmes MC, Burnet FM: The natural history of autoimmune disease in Nzb mice. A comparison with the pattern of human autoimmune manifestations. Ann Intern Med 59: 265-276, 1963
19. Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE: Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab Invest 68: 419-426, 1993
20. Lu R, Vidal GS, Kelly JA, Delgado-Vega AM, Howard XK, Macwana SR, Dominguez N, Klein W, Burrell C, Harley IT, Kaufman KM, Bruner GR, Moser KL, Gaffney PM, Gilkeson GS, Wakeland EK, Li QZ, Langefeld CD, Marion MC, Divers J, Alarcon GS, Brown EE, Kimberly RP, Edberg JC, Ramsey-Goldman R, Reveille JD, McGwin G Jr., Vila LM, Petri MA, Bae SC, Cho SK, Bang SY, Kim I, Choi CB, Martin J, Vyse TJ, Merrill JT, Harley JB, Alarcon-Riquelme ME, Nath SK, James JA, Guthridge JM: Genetic associations of LYN with systemic lupus erythematosus. Genes Immun 10: 397-403, 2009
21. Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, Fukazawa T, Jansen MD, Hashimoto H, van de Winkel JG, Kallenberg CG, Tokunaga K: Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: Contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46: 1242-1254, 2002
22. Kubo T, Uchida Y, Watanabe Y, Abe M, Nakamura A, Ono M, Akira S, Takai T: Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity. J Exp Med 206: 1971-1982, 2009
23. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S: Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312: 1669-1672, 2006 (Pubitemid 43902669)
24. Xiang Z, Cutler AJ, Brownlie RJ, Fairfax K, Lawlor KE, Severinson E, Walker EU, Manz RA, Tarlinton DM, Smith KGC: FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 8: 419-429, 2007 (Pubitemid 46745417)
25. Moser KL, Kelly JA, Lessard CJ, Harley JB: Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 10: 373-379, 2009
26. Arce E, Jackson DG, Gill MA, Bennett LB, Banchereau J, Pascual V: Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 167: 2361-2369, 2001
27. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197: 711-723, 2003
28. Lyons PA, McKinney EF, Rayner TF, Hatton A, Woffendin HB, Koukoulaki M, Freeman TC, Jayne DR, Chaudhry AN, Smith KGC: Novel expression signatures identified by transcriptional analysis of separated leukocyte subsets in SLE and vasculitis. Ann Rheum Dis 69: 1208-1213, 2010
29. Ishikawa H, Ziff M: Electron microscopic observations of immunoreactive cells in the rheumatoid synovial membrane. Arthritis Rheum 19: 1-14, 1976
30. Hill ME, Shiono H, Newsom-Davis J, Willcox N: The myasthenia gravis thymus: A rare source of human autoantibody-secreting plasma cells for testing potential therapeutics. J Neuroimmunol 202: 50-56, 2008
31. Chu VT, Enghard P, Schurer S, Steinhauser G, Rudolph B, Riemekasten G, Berek C: Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus. Arthritis Rheum 60: 2083-2093, 2009
32. Cassese G, Lindenau S, de Boer B, Arce S, Hauser A, Riemekasten G, Berek C, Hiepe F, Krenn V, Radbruch A, Manz RA: Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur J Immunol 31: 2726-2732, 2001 (Pubitemid 32898740)
33. Kallies A, Hasbold J, Tarlinton DM, Dietrich W, Corcoran LM, Hodgkin PD, Nutt SL: Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J Exp Med 200: 967-977, 2004
34. Miller JJ 3rd, Cole LJ: Resistance of long-lived lymphocytes and plasma cells in rat lymph nodes to treatment with prednisone, cyclophosphamide, 6-mercaptopurine, and actinomycin D. J Exp Med 126: 109-125, 1967
35. Soos TJ, Sims TN, Barisoni L, Lin K, Littman DR, Dustin ML, Nelson PJ: CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 70: 591-596, 2006
36. Kruger T, Benke D, Eitner F, Lang A, Wirtz M, Hamilton-Williams EE, Engel D, Giese B, Muller-Newen G, Floege J, Kurts C: Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol 15: 613-621, 2004
37. Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE, Hammerich L, Panzer U, Kaden S, Quaggin SE, Floege J, Grone HJ, Kurts C: Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 119: 1286-1297, 2009
38. Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC: Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 21: 2951-2962, 1991
39. Mohr E, Serre K, Manz RA, Cunningham AF, Khan M, Hardie DL, Bird R, MacLennan IC: Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J Immunol 182: 2113-2123, 2009
40. McKee P: ECaSG. In: Pathology of the skin, New York, Elsevier, 2005
41. Li L, Huang L, Sung SS, Vergis AL, Rosin DL, Rose CE Jr., Lobo PI, Okusa MD: The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 74: 1526-1537, 2008
42. Balabanian K, Couderc J, Bouchet-Delbos L, Amara A, Berrebi D, Foussat A, Baleux F, Portier A, Durand-Gasselin I, Coffman RL, Galanaud P, Peuchmaur M, Emilie D: Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus. J Immunol 170: 3392-3400, 2003
43. Togel F, Isaac J, Hu Z, Weiss K, Westenfelder C: Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 67: 1772-1784, 2005
44. Lotan D, Sheinberg N, Kopolovic J, Dekel B: Expression of SDF-1/CXCR4 in injured human kidneys. Pediatr Nephrol 23: 71-77, 2008
45. Hoffmann U, Banas B, Kruger B, Banas M, Bergler T, Boger C, Kammerl M, Obed A, Rummele P, Segerer S, Riegger GA, Kramer BK: SDF-1 expression is elevated in chronic human renal allograft rejection. Clin Transplant 20: 712-718, 2006
46. Tsubaki T, Takegawa S, Hanamoto H, Arita N, Kamogawa J, Yamamoto H, Takubo N, Nakata S, Yamada K, Yamamoto S, Yoshie O, Nose M: Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts. Clin Exp Immunol 141: 363-371, 2005
47. Blink EJ, Light A, Kallies A, Nutt SL, Hodgkin PD, Tarlinton DM: Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J Exp Med 201: 545-554, 2005 (Pubitemid 40289545)
48. Ito T, Ishikawa S, Sato T, Akadegawa K, Yurino H, Kitabatake M, Hontsu S, Ezaki T, Kimura H, Matsushima K: Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus. J Immunol 172: 3628-3634, 2004
49. Enghard P, Humrich JY, Chu VT, Grussie E, Hiepe F, Burmester GR, Radbruch A, Berek C, Riemekasten G: Class switching and consecutive loss of dsDNA reactive B1a B cells from the peritoneal cavity during murine lupus development. Eur J Immunol 40: 1809-1818, 2010
50. Jones BM, Liu T, Wong RW: Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity. Autoimmunity 31: 117-124, 1999
51. Mellor-Pita S, Citores MJ, Castejon R, Yebra-Bango M, Tutor-Ureta P, Rosado S, Andreu JL, Vargas JA: Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Cytometry B Clin Cytom 76B: 261-270, 2009
52. Xu H, He X, Liu Q, Chen Y, Zhu Y, Shi D, Zhang X: The abnormal high expression of B cell activating factor belonging to TNF superfamily (BAFF) and its potential role in kidney transplant recipients. Cell Mol Immunol 5: 465-470, 2008
53. Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, Suzuki J, Nozawa K, Amano H, Tokano Y, Kobata T, Takasaki Y: Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: The role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Rheumatology (Oxford) 46: 1083-1086, 2007
54. Gurcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR: A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 9: 10-25, 2009
55. Smith KGC, Jones RB, Burns SM, Jayne DR: Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment. Arthritis Rheum 54: 2970-2982, 2006
56. Ferraro AJ, Drayson MT, Savage CO, MacLennan IC: Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab. Eur J Immunol 38: 292-298, 2008